HF
AEON icon

HRT Financial’s AEON Biopharma AEON Stock Holding History

HRT Financial’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,258
Closed -$34K – 2788
2025
Q2 		$34K Buy
+45,258
New +$26K ﹤0.01% 2352
2025
Q1 		– Sell
-287
Closed -$11K – 2458
2024
Q4 		$11K Buy
+287
New +$16.7K ﹤0.01% 2263
2023
Q1 		– Sell
-694
Closed -$502K – 2423
2022
Q4 		$502K Sell
694
-19
-3% -$13.6K 0.01% 1417
2022
Q3 		$505K Hold
713
– – 0.01% 1479
2022
Q2 		$502K Hold
713
– – 0.01% 1516
2022
Q1 		$502K Buy
713
+5
+0.7% +$3.51K ﹤0.01% 1668
2021
Q4 		$495K Buy
+708
New +$498K ﹤0.01% 1857

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's AEON Position: Q3 2025 in Review

HRT Financial sold out of AEON Biopharma (AEON) in Q3 2025, closing a stake of 45,258 shares — an estimated $34K sold.

HRT Financial first reported a position in AEON in Q4 2021 and held it in 7 quarters. The position peaked at $505K in Q3 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q3 2025.

  • HRT Financial reported no remaining AEON Biopharma position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 45,258 AEON Biopharma shares in Q3 2025, an estimated $34K.
  • HRT Financial first reported a position in AEON Biopharma in Q4 2021 and held it in 7 quarters.
  • HRT Financial's AEON Biopharma position peaked at $505K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.